In August 2019 the South African Institute for Drug-Free Sport (SAIDS) has reported an anti-doping rule violation against the rugby player Aphiwe Odwa Dyantyi after his A and B samples tested positive for the prohibited substances Metandienone and LGD-4033 (ligandrol).
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the SAIDS Anti-Doping Tribunal.
The Athlete admitted the violation, denied the intentional use of the substances and explained how the substances entered his system. The Athlete's friend Yawa testified that he had purchased online the products Liquid Ligandrol and Liquid Myostine YK11 in June 2019 and mixed into a Vaso Pump pre-drink for his own consumption, yet by mistake it was consumed by the Athlete.
Both SAIDS and the Athlete tried to find the source of the prohibited substances. After the unwillingness of the online supplier they could only obtain Ligandrol and Myostine YK11 capsules, not liquid Myostine YK11. Analysis of the products in the Salt Lake City Lab confirmed the presence of Metandienone and LGD 4033. Nevertheless SAIDS did not accept the explanations provided by the Athlete and Yawa as to to presence of the prohibited substances.
The Panel considerend the testimony of Jawa and finds him a dishones and misleading witness due to the many inconsistencies and contradictions in his statements.
As a result the Panel deems that the source of the prohibited substances has not been established and that the Athlete failed to demonstrate that the violation was not intentional.
Therefore the SAIDS Anti-Doping Tribunal decides on 6 December 2020 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 13 August 2019.
